Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (2)
  • 2023 (12)
  • 2022 (15)
  • 2021 (15)

Subject

  • Drug Trafficking (287)
  • Synthetic drugs (201)
  • Seizures (Drugs/Property) (198)
  • Task Forces/Task Force Officers (185)
  • Major Law Enforcement Operation (137)
  • Guns/Weapons (131)
  • OCDETF/Task Force (99)
  • Arrests/Convictions - Major (85)
  • Gangs (70)
  • Overdose (70)
  • Guilty Plea (67)
  • Fake Pills (61)
  • Prescription Drugs (60)
  • Pharmaceuticals/Pharmacists/Physicians (46)
  • Narcoterrorism (37)
  • HIDTA (36)
  • Outreach/Drug Prevention (29)
  • Money Laundering (27)
  • Press Conferences (27)
  • Take Back Day (19)
  • One Pill Can Kill (13)
  • Public and Media Affairs - also see Congressional Affairs (12)
  • Fentanyl Awareness (11)
  • Prevention/Education - DEA websites GSAD, JTT etc (11)
  • International/Foreign Operations (10)
  • Dark Web- Internet Trafficking (9)
  • Asset Forfeiture (5)
  • Extraditions (5)
  • Intergovernmental Affairs (3)
  • Counterfeit Pills (2)
  • Museum and Visitors Center (2)
  • Terrorism (2)
  • Campaigns (1)
  • Fentanyl Free America (1)
  • Intelligence Division - Intelligence Products (1)
  • Diversion Division (48)

Drug Name

  • Opioids (21)
  • Oxycodone (14)
  • Synthetic Opioids (9)
  • Fentanyl (6)
  • Hydromorphone (4)
  • Benzodiazepines (3)
  • Steroids (3)
  • Morphine (2)
  • Methadone (1)

Field Division

  • New England (35)
  • Seattle (25)
  • New York (23)
  • Chicago (18)
  • Houston (16)
  • Atlanta (13)
  • Miami (10)
  • Sede (10)
  • New Orleans (8)
  • El Paso (7)
  • San Francisco (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • Washington, DC (34)
  • New Jersey (14)
Clear All Results
48 Results - Showing 1 to 10
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Washington, DC – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment...
PRESS RELEASE

2025 National Health Care Fraud Takedown

ALEXANDRIA, Va. – Erik S. Siebert, U.S. Attorney for the Eastern District of Virginia, announced criminal charges against six defendants. The charges filed in federal court are part of the Department of Justice’s 2025 National Health Care Fraud Takedown . The charges are part of a strategically coordinated, nationwide law...
PRESS RELEASE

Physician Sentenced to 18 Years in Prison for Operating a Pill Mill from His Northwest D.C. Medical Practice

WASHINGTON -- Ndubuisi Joseph Okafor, M.D., 65, of Upper Marlboro, Maryland, was sentenced today in U.S. District Court to 18 years in prison for illegally distributing prescriptions for narcotics in exchange for cash from his Northwest Washington D.C. medical clinic. A jury found Okafor guilty on Mar. 21, 2025, of...
PRESS RELEASE

DEA Safely Disposes 620,000 Pounds of Unused Medication on 28th National Prescription Drug Take Back Day

WASHINGTON D.C. – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Locally, the...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
PRESS RELEASE

DEA’s National Prescription Drug Take Day Removes Almost 600,000 Pounds of Unneeded Prescription Medications Across the Country

WASHINGTON, DC – On October 28, 2023, the community once again emptied their medicine cabinets to help dispose of old, unwanted, and expired medications. Nationwide, DEA and its law enforcement partners collected 599,897 pounds of unneeded medications at 4,675 collection sites nationwide. Locally, the Washington Division, which includes the District...
PRESS RELEASE

DEA Washington Division is Ready to Celebrate the 25th National Drug Take Back Day Across the DMV

Washington, DC – The Drug Enforcement Administration (DEA) will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. in more than 300 collection sites across Maryland, District of Columbia, and Virginia (DMV). Through a collaborative effort with local law enforcement...
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
PRESS RELEASE

Former Chief Operating Officer of Area Pain Clinics Indicted

CHARLOTTESVLLE, Va. – A federal grand jury returned an indictment this week charging the former chief operating officer of area pain clinics with three conspiracy counts for her alleged involvement in health care fraud and illegal drug distribution. Jennifer Ann “Jen” Adams, 50, of Mount Pleasant, South Carolina, is charged...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster